mRNA Capping Technologies & Cap Analog Supply Market
完整報告名稱與涵蓋範圍
mRNA Capping Technologies & Cap Analog Supply Market Size, Share & Trends Analysis Report, By Capping Approach (Co-Transcriptional Cap Analogs (Trinucleotide and Dinucleotide), Post-Transcriptional Enzymatic Capping, Capping Analytics and Quality Control), By Product Type (Cap Analog Reagents, Capping Enzymes and Kits, Licensing and Technology Access, Capping Analytical Services), By Grade (Research Grade, GMP Grade), By End User, By Region, and Segment Forecasts, 2026-2035
報告摘要
The mRNA capping technologies and cap analog supply market covers the reagents, enzymes, licensed technologies and analytical services used to install the 5' cap structure on messenger RNA, including co-transcriptional trinucleotide and dinucleotide cap analogs, post-transcriptional enzymatic capping systems and the analytics that verify capping efficiency. Other in vitro transcription raw materials are covered in adjacent InsightAce studies; a dedicated study addresses enzymatic capping in greater depth.
Capping is one of the most consequential and expensive steps in mRNA manufacturing because cap structure determines translation efficiency, innate immune recognition and regulatory acceptance, and because a single co-transcriptional trinucleotide analog captured most commercial vaccine demand under licence. Developers and manufacturers are now weighing that route against enzymatic capping, which avoids licensing constraints and improves yield for long or self-amplifying RNAs, and against next-generation analogs with modified cap chemistries that improve stability and expression. Cost per gram, GMP supply security, freedom to operate and compatibility with high-throughput analytics such as LC-MS capping assays drive purchasing decisions.
North America and Europe dominate supply and consumption, with China, South Korea and Japan building domestic reagent and enzyme capacity. Competition involves nucleotide and reagent specialists, enzyme manufacturers, diversified life science suppliers and Asian entrants offering alternative chemistries.
The InsightAce study provides US$ revenue forecasts for every capping approach, product type, grade and end user and regional segment over 2026-2035, plus segment trend analysis, competitive landscape mapping and profiles of leading participants.
授權報價
| Single User | $4,500 USD |
| Enterprise / Global Site Licence | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global mRNA Capping Technologies & Cap Analog Supply Market Snapshot
Chapter 4. Global mRNA Capping Technologies & Cap Analog Supply Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Emerging Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis - Porter's Five Forces Analysis
4.7. Competitive Landscape and Market Positioning
4.8. Market Opportunity Analysis
Chapter 5. Market Segmentation 1: By Capping Approach Estimates & Trend Analysis
5.1. Capping Approach & Market Share, 2026 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Capping Approach:
5.2.1. Co-Transcriptional Cap Analogs (Trinucleotide and Dinucleotide)
5.2.2. Post-Transcriptional Enzymatic Capping
5.2.3. Capping Analytics and Quality Control
Chapter 6. Market Segmentation 2: By Product Type Estimates & Trend Analysis
6.1. Product Type & Market Share, 2026 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Product Type:
6.2.1. Cap Analog Reagents
6.2.2. Capping Enzymes and Kits
6.2.3. Licensing and Technology Access
6.2.4. Capping Analytical Services
Chapter 7. Market Segmentation 3: By Grade Estimates & Trend Analysis
7.1. Grade & Market Share, 2026 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by Grade:
7.2.1. Research Grade
7.2.2. GMP Grade
Chapter 8. Market Segmentation 4: By End User Estimates & Trend Analysis
8.1. End User & Market Share, 2026 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analysis, 2026 to 2035, by End User:
8.2.1. mRNA Vaccine and Therapeutics Developers
8.2.2. CDMOs
8.2.3. Academic and Research Institutes
Chapter 9. mRNA Capping Technologies & Cap Analog Supply Market: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. South Korea
9.3.5. Australia
9.3.6. Southeast Asia
9.3.7. Rest of Asia Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Mexico
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. GCC Countries
9.5.2. South Africa
9.5.3. Rest of Middle East & Africa
Chapter 10. Competitive Landscape
10.1. Company Market Positioning Analysis
10.2. Strategic Developments (Partnerships, Expansions, Product Launches, M&A)
Chapter 11. Company Profiles
11.1. TriLink BioTechnologies (Maravai LifeSciences)
11.2. New England Biolabs, Inc.
11.3. Roche CustomBiotech
11.4. Thermo Fisher Scientific Inc.
11.5. Kactus Bio
11.6. Jena Bioscience GmbH
11.7. Hongene Biotech Corporation
11.8. Merck KGaA (MilliporeSigma)
11.9. Vazyme Biotech Co., Ltd.
11.10. ST Pharm Co., Ltd.
11.11. Aldevron (Danaher)
11.12. Takara Bio Inc.
11.13. Creative Biolabs
11.14. GenScript Biotech Corporation
11.15. Novozymes (Novonesis) Enzyme Supply
圖表清單 List of Tables & Figures
Table 1. Global mRNA Capping Technologies & Cap Analog Supply Revenue Forecast by Capping Approach, 2026-2035 (US$ Mn)
Figure 1. Global mRNA Capping Technologies & Cap Analog Supply Market Snapshot, 2026 & 2035
Table 2. Global mRNA Capping Technologies & Cap Analog Supply Revenue Forecast by Product Type, 2026-2035 (US$ Mn)
Figure 2. Global mRNA Capping Technologies & Cap Analog Supply Market Share by Product Type, 2026 & 2035
Table 3. Global mRNA Capping Technologies & Cap Analog Supply Revenue Forecast by Grade, 2026-2035 (US$ Mn)
Figure 3. Co-Transcriptional Versus Enzymatic Capping: Cost, Yield and Licensing Comparison
Table 4. Global mRNA Capping Technologies & Cap Analog Supply Revenue Forecast by End User, 2026-2035 (US$ Mn)
Figure 4. Cap Analog and Capping Enzyme Supply Chain and Capacity by Region
Table 5. North America mRNA Capping Technologies & Cap Analog Supply Revenue by Country, 2026-2035 (US$ Mn)
Figure 5. Asia Pacific mRNA Capping Technologies & Cap Analog Supply Growth Opportunity Analysis
Table 6. Europe mRNA Capping Technologies & Cap Analog Supply Revenue by Country, 2026-2035 (US$ Mn)
Figure 6. Next-Generation Cap Chemistry Innovations and Their Effect on mRNA Performance
Table 7. Asia Pacific mRNA Capping Technologies & Cap Analog Supply Revenue by Country, 2026-2035 (US$ Mn)
Figure 7. Competitive Positioning of Key mRNA Capping Technologies & Cap Analog Supply Market Participants
Table 8. Latin America and Middle East & Africa mRNA Capping Technologies & Cap Analog Supply Revenue Forecast, 2026-2035 (US$ Mn)
提及公司
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們